Business
Highly Accomplished Executives Join BioVie’s Board of Directors
Hariri, Gorlin, and Rogich to Contribute Their Tremendous Industry Insights and Stature SANTA MONICA, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- BioVie, Inc.
About this update from Biovie Inc.
[{"type":"text","content":"Hariri, Gorlin, and Rogich to Contribute Their Tremendous Industry Insights and Stature\n SANTA MONICA, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- BioVie, Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, is pleased to announce the appointments of Dr. Robert Hariri, Mr. Steve Gorlin, and Mr. Sig Rogich to its Board of Directors. Terren Peizer, BioVie’s Chairman and Chief Executive Officer commented, “We are humbled to have these industry titans join our company. Robert has leveraged his deep expertise in biology to pioneer and found leading-edge life science companies. Steve has been founder and initial investor in many successful biopharma companies. Sig has served multiple US presidents over the years and has been dedicated to improving Alzheimer’s disease patient care. The new directors join current member and industry leader Cuong Do, who was formerly Chief Strategy Officer at Merck & Co. and currently President of Samsung Global Strategy Group. The combination of unique talents and capabilities of these distinguished gentlemen will greatly benefit BioVie as we advance the Company. Mr. Steve Gorlin has founded many biotechnology and pharmaceutical companies over the past forty-five years, including Hycor Biomedical, Inc. (acquired by Agilent), Theragenics Corporation, Medicis Pharmaceutical Corporation (sold to Valeant for approximately $2.6 billion), EntreMed, Inc., MRI Interventions (MRIC), DARA BioSciences, Inc., MiMedx, Medivation, Inc., sold to Pfizer for $14 billion and Conkwest which became NantKwest. Mr. Gorlin served for many years on the Business Advisory Council to the Johns Hopkins School of Medicine and on The Johns Hopkins BioMedical Engineering Advisory Board. He also served on the Board of the Andrews Institute. He is currently a member of the Research Institute Advisory Committee (RIAC) of Massachusetts General Hospital. He started The Touch Foundation, a nonprofit organization for the blind and was a principal financial contributor to the founding of Camp Kudzu for diabetic children. Robert J. Hariri, MD, PhD, is the chairman, founder, and chief executive officer of Celularity, Inc., a leading human cellular therapeutics company. Dr. Hariri was the founder and CEO of Anthrogenesis Corporation, and after its acquisition by Celgene Corp...